China Pioneer Pharma Holdings Limited (1345.HK)

HKD 2.23

(0.0%)

Net Debt Summary of China Pioneer Pharma Holdings Limited

  • China Pioneer Pharma Holdings Limited's latest annual net debt in 2023 was -40.4 Million CNY , up 77.1% from previous year.
  • China Pioneer Pharma Holdings Limited's latest quarterly net debt in 2023 FY was -40.4 Million CNY , up 77.1% from previous quarter.
  • China Pioneer Pharma Holdings Limited reported annual net debt of -176.41 Million CNY in 2022, up 16.31% from previous year.
  • China Pioneer Pharma Holdings Limited reported annual net debt of -210.8 Million CNY in 2021, down -111.0% from previous year.
  • China Pioneer Pharma Holdings Limited reported quarterly net debt of -40.4 Million CNY for 2023 Q4, down 0.0% from previous quarter.
  • China Pioneer Pharma Holdings Limited reported quarterly net debt of -40.4 Million CNY for 2023 FY, up 77.1% from previous quarter.

Annual Net Debt Chart of China Pioneer Pharma Holdings Limited (2023 - 2012)

Historical Annual Net Debt of China Pioneer Pharma Holdings Limited (2023 - 2012)

Year Net Debt Net Debt Growth
2023 -40.4 Million CNY 77.1%
2022 -176.41 Million CNY 16.31%
2021 -210.8 Million CNY -111.0%
2020 -99.9 Million CNY 54.85%
2019 -221.25 Million CNY -345.03%
2018 -49.71 Million CNY 73.42%
2017 -187.02 Million CNY 14.59%
2016 -218.97 Million CNY -1474.76%
2015 -13.9 Million CNY -103.87%
2014 358.9 Million CNY 231.69%
2013 -272.52 Million CNY -176.41%
2012 356.66 Million CNY 0.0%

Peer Net Debt Comparison of China Pioneer Pharma Holdings Limited

Name Net Debt Net Debt Difference
China Healthwise Holdings Limited 94.47 Million HKD 142.768%
Tycoon Group Holdings Limited 167.05 Million HKD 124.187%
Beijing Tong Ren Tang Chinese Medicine Company Limited -868 Million HKD 95.345%